MYOSのニュース
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding 2020/11/17 13:00:00 PR Newswire
CEDAR KNOLLS, N.J., Nov. 17, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada corporation ("MYOS"), and MedAvail, Inc., a privately-held Delaware corporation…
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger 2020/11/12 21:30:00 PR Newswire
CEDAR KNOLLS, N.J., Nov. 12, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada corporation ("MYOS"), and MedAvail, Inc., a privately-held Delaware corporation…
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020 2020/11/06 15:00:00 PR Newswire
CEDAR KNOLLS, N.J., Nov. 6, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announced today its results for the three and…
85 Stocks Moving In Wednesday's Mid-Day Session 2020/08/05 12:02:00 Benzinga
Gainers Biofrontera AG (NASDAQ: BFRA) climbed 151.8% to $14.10. MYOS RENS Technology Inc. (NASDAQ: MYOS) shares climbed 73.4% to $2.15 after the company …
MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020 2020/08/05 12:00:00 PR Newswire
CEDAR KNOLLS, N.J., Aug. 5, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announces its results for the three and six…